The intricate dance of hormones plays a pivotal role in regulating appetite and feelings of fullness, and semaglutide has been shown to significantly influence this balance
For individuals with Type 2 diabetes, who are at an increased risk for heart disease, GLP-1 therapy has been shown to lower the risk of heart attack, stroke, and other cardiovascular events
A study presented recently at ARVO 2026 analyzed the incidence of glaucoma, macular and ophthalmic diseases over a four-year period among non-diabetic adults prescribed GLP-1 drugs and found these medications provide a variety of protective signals
A study from a 2016 edition of Cell Reports found that increased NAD + levels improved markers of obesity and insulin resistance in mice
Clinical Evidence Supplement marketing frequently moves too quickly from mechanism to outcome
She is also Professor of Physical Medicine and Rehabilitation at Weill Cornell Medicine and a Diplomate of the American Board of Lifestyle Medicine.